User profiles for N. Sprigg

Nikola Sprigg

University of Nottingham
Verified email at nottingham.ac.uk
Cited by 8725

Post-stroke dysphagia: a review and design considerations for future trials

…, C Smith, D Smithard, N Sprigg… - … Journal of Stroke, 2016 - journals.sagepub.com
Post-stroke dysphagia (a difficulty in swallowing after a stroke) is a common and expensive
complication of acute stroke and is associated with increased mortality, morbidity, and …

Hypercholesterolaemia and vascular dementia

JP Appleton, P Scutt, N Sprigg, PM Bath - Clinical Science, 2017 - portlandpress.com
… In those with a history of cerebrovascular disease in HPS (n=3,280), simvastatin was
associated with a 20% reduction in major cardiovascular events compared with placebo, but there …

Twenty proteins containing a C-terminal SOCS box form five structural classes

…, EM Viney, TA Willson, NS Sprigg… - Proceedings of the …, 1998 - National Acad Sciences
… Structurally, the SOCS proteins are composed of an N-terminal region of variable length …
These proteins fall into five classes based on the protein motifs found N-terminal of the SOCS …

[HTML][HTML] SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine

…, R Starr, JE Fenner, CL Scott, E Handman, NS Sprigg… - Cell, 1999 - cell.com
Mice lacking suppressor of cytokine signaling-1 (SOCS1) develop a complex fatal neonatal
disease. In this study, SOCS1 −/− mice were shown to exhibit excessive responses typical of …

[HTML][HTML] Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

N Sprigg, K Flaherty, JP Appleton, RAS Salman… - The Lancet, 2018 - thelancet.com
Background Tranexamic acid can prevent death due to bleeding after trauma and post-partum
haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma …

[HTML][HTML] Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded …

…, JM Wardlaw, LJ Woodhouse, G Venables, N Sprigg… - The Lancet, 2019 - thelancet.com
Background High blood pressure is common in acute stroke and is a predictor of poor
outcome; however, large trials of lowering blood pressure have given variable results, and the …

[HTML][HTML] The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster …

…, JJ Miranda, CS Anderson, A Parry-Jones, N Sprigg… - The Lancet, 2023 - thelancet.com
Background Early control of elevated blood pressure is the most promising treatment for
acute intracerebral haemorrhage. We aimed to establish whether implementing a goal-directed …

[HTML][HTML] Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

…, GD Murray, J Stephen, DE Newby, N Sprigg… - The Lancet, 2019 - thelancet.com
Background Antiplatelet therapy reduces the risk of major vascular events for people with
occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. …

[HTML][HTML] Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia …

…, TG Robinson, P Scutt, GS Venables, N Sprigg… - The Lancet, 2018 - thelancet.com
Background Intensive antiplatelet therapy with three agents might be more effective than
guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. …